Neonatal Group B Streptococcus Disease
- PMID: 38296778
- PMCID: PMC10919294
- DOI: 10.1542/pir.2023-006154
Neonatal Group B Streptococcus Disease
Abstract
Group B Streptococcus (GBS) is an important cause of neonatal sepsis in term and preterm infants. Because GBS colonizes human genitourinary and gastrointestinal tracts, a significant focus of neonatal GBS disease prevention is to interrupt vertical transmission of GBS from mother to infant during parturition. Routine antepartum GBS screening in pregnant women, as well as widespread use of intrapartum antibiotic prophylaxis, have aided in overall reductions in neonatal GBS disease during the past 3 decades. However, neonatal GBS disease persists and may cause mortality and significant short- and long-term morbidity among survivors. Herein, we highlight contemporary epidemiology, microbial pathogenesis, and the clinical presentation spectrum associated with neonatal GBS disease. We summarize obstetric recommendations for antenatal GBS screening, indications for intrapartum antibiotic prophylaxis, and considerations for antibiotic selection. Finally, we review national guidelines for risk assessment and management of infants at risk for GBS disease.
© American Academy of Pediatrics, 2024. All rights reserved.
Figures
References
-
- Regan JA, Klebanoff MA, Nugent RP. The epidemiology of group B streptococcal colonization in pregnancy. Vaginal Infections and Prematurity Study Group. Obstet Gynecol. 1991;77(4):604–610. http://www.ncbi.nlm.nih.gov/pubmed/2002986. - PubMed
-
- Committee on Infectious Diseases. Group B Streptococcal Infections. In: Kimberlin, MD, FAAP David W., Barnett, MD, FAAP Elizabeth D., Lynfield, MD, FAAP Ruth, Sawyer, MD Mark H., ed. Red Book: 2021–2024 Report of the Committee on Infectious Diseases. 32nd ed. American Academy of Pediatrics; 2021. doi:10.1016/B0-72-160537-0/50015-3 - DOI
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
